Reference record for OID 2.16.840.1.113883.11.21026

Parent
2.16.840.1.113883.11 (valueSets)
Node code
21026
Node names
  • AdverseEventCRSerCrit
  • adverse-event-clinical-research-seriousness-criteria
Numeric OID
2.16.840.1.113883.11.21026
URN notation
urn:oid:2.16.840.1.113883.11.21026
ASN.1 notation

{2 16 840 1 113883 11 21026}

  • {joint-iso-itu-t(2) country(16) us(840) organization(1) hl7(113883) valueSets(11) adverse-event-clinical-research-seriousness-criteria(21026)}
  • {joint-iso-itu-t(2) country(16) us-joint(840) organization(1) hl7(113883) valueSets(11) adverse-event-clinical-research-seriousness-criteria(21026)}
  • {joint-iso-ccitt(2) country(16) us(840) organization(1) hl7(113883) valueSets(11) adverse-event-clinical-research-seriousness-criteria(21026)}
  • {joint-iso-ccitt(2) country(16) us-joint(840) organization(1) hl7(113883) valueSets(11) adverse-event-clinical-research-seriousness-criteria(21026)}
OID-IRI notation
  • /2/16/840/1/113883/11/21026
  • /Country/840/1/113883/11/21026
  • /Joint-ISO-ITU-T/16/840/1/113883/11/21026
Named path variants
  • /joint-iso-itu-t/country/us/organization/hl7/valueSets/AdverseEventCRSerCrit
  • /joint-iso-itu-t/country/us/organization/hl7/valueSets/adverse-event-clinical-research-seriousness-criteria
  • /joint-iso-itu-t/country/us/organization/HL7/valueSets/AdverseEventCRSerCrit
  • /joint-iso-itu-t/country/us/organization/HL7/valueSets/adverse-event-clinical-research-seriousness-criteria
  • /joint-iso-itu-t/country/us-joint/organization/hl7/valueSets/AdverseEventCRSerCrit
  • /joint-iso-itu-t/country/us-joint/organization/hl7/valueSets/adverse-event-clinical-research-seriousness-criteria
  • /joint-iso-itu-t/country/us-joint/organization/HL7/valueSets/AdverseEventCRSerCrit
  • /joint-iso-itu-t/country/us-joint/organization/HL7/valueSets/adverse-event-clinical-research-seriousness-criteria
  • /joint-iso-ccitt/country/us/organization/hl7/valueSets/AdverseEventCRSerCrit
  • /joint-iso-ccitt/country/us/organization/hl7/valueSets/adverse-event-clinical-research-seriousness-criteria
  • /joint-iso-ccitt/country/us/organization/HL7/valueSets/AdverseEventCRSerCrit
  • /joint-iso-ccitt/country/us/organization/HL7/valueSets/adverse-event-clinical-research-seriousness-criteria
  • /joint-iso-ccitt/country/us-joint/organization/hl7/valueSets/AdverseEventCRSerCrit
  • /joint-iso-ccitt/country/us-joint/organization/hl7/valueSets/adverse-event-clinical-research-seriousness-criteria
  • /joint-iso-ccitt/country/us-joint/organization/HL7/valueSets/AdverseEventCRSerCrit
  • /joint-iso-ccitt/country/us-joint/organization/HL7/valueSets/adverse-event-clinical-research-seriousness-criteria

Descriptions

AdverseEventCRSerCrit, adverse-event-clinical-research-seriousness-criteria — HL7 Terminology

Action criteria usually associated with serious events that pose a threat to a patient's life or functioning. Adverse Events criteria to expand on the seriousness of the adverse event. Typically used in reporting for Clinical Research, post-market surveillance (e.g. Form FDA 3500A MedWatch). The adverse event seriousness criteria value set is based on the ICH E2D Post-Approval Safety Data Management: Definitions and Standards for Expedited Reporting guidance (https://database.ich.org/sites/default/files/E2D_Guideline.pdf). For information on ICH see https://admin.ich.org/sites/default/files/inline-files/OID_Information_Paper_1.pdf from the INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE (ICH) document ICH E2B(R3), the Electronic Transmission of Individual Case Safety Reports (ICSRs) Implementation Guide Data Elements and Message Specification, and ICH M8, the Electronic Common Technical Document

Source records

AdverseEventCRSerCrit, adverse-event-clinical-research-seriousness-criteria

Status in source: active.

Names: AdverseEventCRSerCrit, adverse-event-clinical-research-seriousness-criteria

Technical details
{
  "url": "http://terminology.hl7.org/ValueSet/adverse-event-clinical-research-seriousness-criteria",
  "date": "2023-07-28T19:27:19+00:00",
  "title": "Adverse Event Clinical Research Seriousness Criteria",
  "status": "active",
  "contact": [
    {
      "telecom": [
        {
          "value": "http://hl7.org",
          "system": "url"
        },
        {
          "value": "hq@HL7.org",
          "system": "email"
        }
      ]
    }
  ],
  "version": "1.0.0",
  "copyright": "This material derives from the HL7 Terminology THO. THO is copyright ©1989+ Health Level Seven International and is made available under the CC0 designation. For more licensing information see: https://terminology.hl7.org/license.html",
  "publisher": "Health Level Seven International",
  "experimental": false,
  "resource_type": "ValueSet",
  "oid_identifier": {
    "value": "urn:oid:2.16.840.1.113883.11.21026",
    "system": "urn:ietf:rfc:3986"
  }
}

First Registration Authority (inferred from ancestor 2.16.840.1.113883)

W. Ted Klein

Current Registration Authority (inferred from ancestor 2.16.840.1)

Karen Hughes

Siblings (1453)

OIDNameDirect childrenDescendantsDescription
2.16.840.1.113883.11.17795 heightSurfaceAreaAlert, HeightSurfaceAreaAlert00
2.16.840.1.113883.11.17807 therapeuticProductDetectedIssueCode, TherapeuticProductDetectedIssueCode00
2.16.840.1.113883.11.17814 clinicalActionDetectedIssueCode, ClinicalActionDetectedIssueCode00
2.16.840.1.113883.11.17815 drugActionDetectedIssueCode, DrugActionDetectedIssueCode00
2.16.840.1.113883.11.17816 timingDetectedIssueCode, TimingDetectedIssueCode00
2.16.840.1.113883.11.17860 nameRepresentationUse, NameRepresentationUse00
2.16.840.1.113883.11.17887 deliveryAddressLine, DeliveryAddressLine00
2.16.840.1.113883.11.17893 actClassROI, ActClassROI00
2.16.840.1.113883.11.17896 actBoundedROICode, ActBoundedROICode00
2.16.840.1.113883.11.17930 naturalChild, NaturalChild00
2.16.840.1.113883.11.17958 actProductAcquisitionCode, ActProductAcquisitionCode00
2.16.840.1.113883.11.17959 transfer, Transfer00
2.16.840.1.113883.11.17961 loan, Loan00
2.16.840.1.113883.11.17963 x-ActFinancialProductAcquisitionCode00 x_ActFinancialProductAcquisitionCode
2.16.840.1.113883.11.17968 actAdjudicationGroupCode, ActAdjudicationGroupCode00
2.16.840.1.113883.11.18105 x-PayeeRelationshipRoleType00 x_PayeeRelationshipRoleType
2.16.840.1.113883.11.18120 partialCompletionScale, PartialCompletionScale00
2.16.840.1.113883.11.18130 americanIndianAlaskaNativeLanguages, AmericanIndianAlaskaNativeLanguages00
2.16.840.1.113883.11.18131 algic, Algic00
2.16.840.1.113883.11.18132 algonquian, Algonquian00
2.16.840.1.113883.11.18135 creeMontagnais, CreeMontagnais00
2.16.840.1.113883.11.18136 cree, Cree00
2.16.840.1.113883.11.18142 arapahoan, Arapahoan00
2.16.840.1.113883.11.18143 arapahoGrosVentre, ArapahoGrosVentre00
2.16.840.1.113883.11.18156 ojibwayan, Ojibwayan00
2.16.840.1.113883.11.18164 saukFoxKickapoo, SaukFoxKickapoo00
2.16.840.1.113883.11.18171 easternAlgonquin, EasternAlgonquin00
2.16.840.1.113883.11.18174 abenakian, Abenakian00
2.16.840.1.113883.11.18184 delawaran, Delawaran00
2.16.840.1.113883.11.18189 ritwan, Ritwan00
2.16.840.1.113883.11.18191 eskimoAleut, EskimoAleut00
2.16.840.1.113883.11.18192 eskimoan, Eskimoan00
2.16.840.1.113883.11.18193 sirenikskiYupik, SirenikskiYupik00
2.16.840.1.113883.11.18210 inuitInupiaq, InuitInupiaq00
2.16.840.1.113883.11.18221 aleut, Aleut00
2.16.840.1.113883.11.18223 caddoan, Caddoan00
2.16.840.1.113883.11.18224 northernCaddoan, NorthernCaddoan00
2.16.840.1.113883.11.18233 southernCaddoan, SouthernCaddoan00
2.16.840.1.113883.11.18238 chimakuan, Chimakuan00
2.16.840.1.113883.11.18241 hokan, Hokan00
2.16.840.1.113883.11.18244 shasta, Shasta00
2.16.840.1.113883.11.18248 palaihnihan, Palaihnihan00
2.16.840.1.113883.11.18253 pomoan, Pomoan00
2.16.840.1.113883.11.18274 cochimiYuman, CochimiYuman00
2.16.840.1.113883.11.18275 yuman, Yuman00
2.16.840.1.113883.11.18276 pai, Pai00
2.16.840.1.113883.11.18282 river, River00
2.16.840.1.113883.11.18291 deltaCalifornia, DeltaCalifornia00
2.16.840.1.113883.11.18292 diegueno, Diegueno00
2.16.840.1.113883.11.18306 iroquoian, Iroquoian00